Navigation Links
Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
Date:5/28/2008

ROCKVILLE, Md., May 28 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the FBR Capital Markets 12th Annual Spring Investor Conference at 9:45 am. on May 29, 2008 at The Grand Hyatt Hotel in New York. Dr. Singhvi will provide an overview of the company's strategy, research and development progress. A link to the live presentation can be accessed via the Company website at http://www.novavax.com. An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.

ABOUT NOVAVAX

Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary viruslike particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing a new, efficient manufacturing solution. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
2. Novavax Reports First Quarter 2008 Financial Results
3. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
4. Novavax Opens Its First U.S. Vaccine Plant
5. Novavax CEO to Present at the World Vaccine Congress 2008
6. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
7. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
8. Novavax CEO to Present at BIO CEO & Investor Conference
9. NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update
10. Abbott to Present at Goldman Sachs Global Healthcare Conference
11. 3SBio Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...if.,Nov.24/PRNewswire/--Twomoreprestigiousuniversi...linejobboardandcareerssiteforlifescienceprofession...membersofthejobboard,joining28othermajorlifescienc...areercenter.com ,isonlyforpost-graduatesinthelifes...tesontheInternet,BioCareerCenteristheonlyonethatse...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs ...show consistent growth during the U.S. recession. ... trouble, and health systems are coming closer to ...of just administrators. , ...nt continued growing in October despite the sheddi...
(Date:11/24/2009)...24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,C...rovedthe,investigationalnewdrugapplication(IND)for...formulationtotreatdiabetes.ThisIND,approvalallowsB..., Diabetesisadisordercharacteristicofhighbloodgluc...tenresultinseveremicro-and,macro-vasculardiseases,...
(Date:11/24/2009)...L , TORONTO,Nov.24/PRNewswire-FirstCall/-Hami...c.,aleadingproviderofadvancedlasersystemsandinstru...ts,todayreportedoperationalandfinancialresultsfort...hlights,-Revenuewas$1.46millioncomparedwith$1.43m...paredwith66.1percentinQ3,2008,-Netlossreducedto$14...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
...uticals,Inc. (Nasdaq: ANDS ), a clinical-stage bi...ient care by developing novel medicines in the are... financial results and,highlights for the third qu...make rapid progress in both of our hepatitis C,dev...ident and CEO of,Anadys. "We completed our first c...
...all/ - Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ... Phase I,Study to Evaluate Systemic Wild-Type Reov...n Patients with Advanced Malignancies" will be ava...al of Immunotherapy, the official,journal of the I...cer,(iSBTc). The principal investigator for the tr...
...ne today announced,that researchers will present e... at the Annual Meeting of the American College of ...oscone Center in San Francisco, California., "Med...ns for patients,struggling with systemic autoimmun...ice president, clinical development, respiratory,i...
Other Biology Technology:Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 2Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 3Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 4Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 5Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 6Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 7Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 8Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting 2Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting 3MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology 2MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology 3
(Date:11/23/2009)...des "incontrovertible evidence" that the volcanic ...out 73,000 years ago deforested much of central In...ers report. , The volcano ejected an estimated 8...aving a crater (now the world,s largest volcanic l... wide. Ash from the event has been found in India,...
(Date:11/23/2009)...USDOE and USDA study concluded that 50 million U.S...asture could be converted from current uses to the...ass, from which biomass could be harvested for use...ction of a perennial grass monoculture from which ...ally is expected to require nitrogen fertilizer. ,...
(Date:11/23/2009)...eal in unprecedented detail how the ribosome inter... and guide them toward their destination in biolog...exible fitting (MDFF) to examine the interaction o...rs. , The first study, in Proceedings of the N...e signaling between the ribosome and an elongation...
Breaking Biology News(10 mins):Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Switchgrass produces biomass efficiently 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years 3A DURATION 1 Interim Long Term Data Present 4551 1Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years 3A DURATION 1 Interim Long Term Data Present 4551 2Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years 3A DURATION 1 Interim Long Term Data Present 4551 3Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years 3A DURATION 1 Interim Long Term Data Present 4551 4Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years 3A DURATION 1 Interim Long Term Data Present 4551 5Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years 3A DURATION 1 Interim Long Term Data Present 4551 6Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years 3A DURATION 1 Interim Long Term Data Present 4551 7Study Shows GSKs Novel Diabetes Treatment SYNCRIA 28R 29 28albiglutide 29 Improves Glucose Control and Reduces Weight 4549 1Study Shows GSKs Novel Diabetes Treatment SYNCRIA 28R 29 28albiglutide 29 Improves Glucose Control and Reduces Weight 4549 2Study Shows GSKs Novel Diabetes Treatment SYNCRIA 28R 29 28albiglutide 29 Improves Glucose Control and Reduces Weight 4549 3Orange County Laser Surgeon Nissan Pilest Tapped as Keynote Speaker at Fraxel 26amp 3B Thermage User Forum Held at Beckman Laser Institute 12498 1Orange County Laser Surgeon Nissan Pilest Tapped as Keynote Speaker at Fraxel 26amp 3B Thermage User Forum Held at Beckman Laser Institute 12498 2Orange County Laser Surgeon Nissan Pilest Tapped as Keynote Speaker at Fraxel 26amp 3B Thermage User Forum Held at Beckman Laser Institute 12498 3
... In recent years, a growing scarcity of energy com...ey geopolitical risks and threats, such as conflic...nalism. However, a study released this week by Ric...uggests that, taken individually, many of the risk...rophic than they seem at first glance. The executi...
... Fishery biologist Sandy Sutherland looks through ...h earbones, known as otoliths, each showing annual...o determine the age of the fish, then moves on to ...nd is one of a small team at NOAAs Northeast Fishe...itical to stock assessments needed to manage the n...
... This press release is available in German . , ...cost us in the long term" How much do national eco...nd" And what price will we have to pay if we do no...nomics of Ecosystems and Biodiversity - project is...ukhdev, who is head of Deutsche Bank,s Global Mark...
Other Biology News:Baker Institute study, conference weigh risks for global energy markets 2Saltwater sleuths: Seeking clues to help determine the ages of fish and shellfish populations 2Saltwater sleuths: Seeking clues to help determine the ages of fish and shellfish populations 3Saltwater sleuths: Seeking clues to help determine the ages of fish and shellfish populations 4Biodiversity as a natural resource 2
...llow 5-minute cloning and subsequent sequencing of...rs with primer sites located as close as 33 base p...imizes the amount of vector DNA that needs to be r...ctors are available. The pCR4-TOPO vector provides...
Transfer & Blot Paper from NuSep Ltd
Dynabeads M-450 Epoxy from Dynal Biotech
GIBCO Earles Balanced Salt Solution (EBSS) (1X); liquid from Invitrogen
Biology Products: